subject: CHEBI:8988

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:8988

object_name: clear cell renal carcinoma

tested_intervention: unsure


subject: CHEBI:8988

object_name: Stage II Renal Cell Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage II Renal Cell Cancer


subject: CHEBI:8988

object_name: Stage II Renal Cell Cancer AJCC v7


subject: CHEBI:8988

object_name: Stage I Renal Cell Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage I Renal Cell Carcinoma


subject: CHEBI:8988

object_name: childhood kidney cell carcinoma


subject: CHEBI:8988

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:8988

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:8988

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage III renal cell cancer


subject: CHEBI:8988

object_name: Stage III Renal Cell Cancer AJCC v7


subject: CHEBI:8988

object_name: clear cell sarcoma of kidney


subject: CHEBI:8988

object_name: papillary renal cell carcinoma


subject: CHEBI:8988

object_name: Stage II Kidney Wilms Tumor


subject: CHEBI:8988

object_name: Stage I Kidney Wilms Tumor


subject: CHEBI:8988

object_name: Stage III Kidney Wilms Tumor


subject: CHEBI:8988

object_name: Stage IV Kidney Wilms Tumor


subject: CHEBI:80630

subject_name: Irinotecan

object_name: rhabdoid tumor of the kidney


subject: CHEBI:80630

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:80630

object_name: clear cell renal carcinoma


subject: CHEBI:80630

object_name: Stage II Renal Cell Cancer AJCC v8


subject: CHEBI:80630

object_name: Stage II Renal Cell Cancer


subject: CHEBI:80630

object_name: Stage II Renal Cell Cancer AJCC v7


subject: CHEBI:80630

object_name: Stage I Renal Cell Cancer AJCC v8


subject: CHEBI:80630

object_name: Stage I Renal Cell Carcinoma


subject: CHEBI:80630

object_name: childhood kidney cell carcinoma


subject: CHEBI:80630

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:80630

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:80630

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:80630

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:80630

object_name: Stage III renal cell cancer


subject: CHEBI:80630

object_name: Stage III Renal Cell Cancer AJCC v7


subject: CHEBI:80630

object_name: clear cell sarcoma of kidney


subject: CHEBI:80630

object_name: papillary renal cell carcinoma


subject: CHEBI:80630

object_name: Stage II Kidney Wilms Tumor


subject: CHEBI:80630

object_name: Stage I Kidney Wilms Tumor


subject: CHEBI:80630

object_name: Stage III Kidney Wilms Tumor


subject: CHEBI:80630

object_name: Stage IV Kidney Wilms Tumor


subject: UNII:T5IRO3534A

subject_name: Oncovin

object_name: rhabdoid tumor of the kidney


subject: UNII:T5IRO3534A

object_name: nonpapillary renal cell carcinoma


subject: UNII:T5IRO3534A

object_name: clear cell renal carcinoma


subject: UNII:T5IRO3534A

object_name: Stage II Renal Cell Cancer AJCC v8


subject: UNII:T5IRO3534A

object_name: Stage II Renal Cell Cancer


subject: UNII:T5IRO3534A

object_name: Stage II Renal Cell Cancer AJCC v7


subject: UNII:T5IRO3534A

object_name: Stage I Renal Cell Cancer AJCC v8


subject: UNII:T5IRO3534A

object_name: Stage I Renal Cell Carcinoma


subject: UNII:T5IRO3534A

object_name: childhood kidney cell carcinoma


subject: UNII:T5IRO3534A

object_name: Stage IV Renal Cell Cancer


subject: UNII:T5IRO3534A

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UNII:T5IRO3534A

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UNII:T5IRO3534A

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UNII:T5IRO3534A

object_name: Stage III renal cell cancer


subject: UNII:T5IRO3534A

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UNII:T5IRO3534A

object_name: clear cell sarcoma of kidney


subject: UNII:T5IRO3534A

object_name: papillary renal cell carcinoma


subject: UNII:T5IRO3534A

object_name: Stage II Kidney Wilms Tumor


subject: UNII:T5IRO3534A

object_name: Stage I Kidney Wilms Tumor


subject: UNII:T5IRO3534A

object_name: Stage III Kidney Wilms Tumor


subject: UNII:T5IRO3534A

object_name: Stage IV Kidney Wilms Tumor


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine

object_name: rhabdoid tumor of the kidney


subject: PUBCHEM.COMPOUND:3717450

object_name: nonpapillary renal cell carcinoma


subject: PUBCHEM.COMPOUND:3717450

object_name: clear cell renal carcinoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage II Renal Cell Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage II Renal Cell Cancer


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage II Renal Cell Cancer AJCC v7


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage I Renal Cell Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage I Renal Cell Carcinoma


subject: PUBCHEM.COMPOUND:3717450

object_name: childhood kidney cell carcinoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage IV Renal Cell Cancer


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage III Renal Cell Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage III renal cell cancer


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage III Renal Cell Cancer AJCC v7


subject: PUBCHEM.COMPOUND:3717450

object_name: clear cell sarcoma of kidney


subject: PUBCHEM.COMPOUND:3717450

object_name: papillary renal cell carcinoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage II Kidney Wilms Tumor


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage I Kidney Wilms Tumor


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage III Kidney Wilms Tumor


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage IV Kidney Wilms Tumor


subject: CHEBI:28445

subject_name: vincristine

object_name: rhabdoid tumor of the kidney


subject: CHEBI:28445

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:28445

object_name: clear cell renal carcinoma


subject: CHEBI:28445

object_name: Stage II Renal Cell Cancer AJCC v8


subject: CHEBI:28445

object_name: Stage II Renal Cell Cancer


subject: CHEBI:28445

object_name: Stage II Renal Cell Cancer AJCC v7


subject: CHEBI:28445

object_name: Stage I Renal Cell Cancer AJCC v8


subject: CHEBI:28445

object_name: Stage I Renal Cell Carcinoma


subject: CHEBI:28445

object_name: childhood kidney cell carcinoma


subject: CHEBI:28445

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:28445

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:28445

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:28445

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:28445

object_name: Stage III renal cell cancer


subject: CHEBI:28445

object_name: Stage III Renal Cell Cancer AJCC v7


subject: CHEBI:28445

object_name: clear cell sarcoma of kidney


subject: CHEBI:28445

object_name: papillary renal cell carcinoma


subject: CHEBI:28445

object_name: Stage II Kidney Wilms Tumor


subject: CHEBI:28445

object_name: Stage I Kidney Wilms Tumor


subject: CHEBI:28445

object_name: Stage III Kidney Wilms Tumor


subject: CHEBI:28445

object_name: Stage IV Kidney Wilms Tumor


subject: UMLS:C1831965

object_name: cancer

tested_intervention: yes


subject: UMLS:C1831965

object_name: neoplasm


subject: PUBCHEM.COMPOUND:71455937

object_name: Nonsense mutation


subject: PUBCHEM.COMPOUND:71455937

object_name: genetic disease


subject: CHEMBL.COMPOUND:CHEMBL4297744


subject: CHEMBL.COMPOUND:CHEMBL4297744


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: Ischemic stroke


subject: PUBCHEM.COMPOUND:22976653

object_name: Alteplase adverse reaction


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: UNII:1RXS4UE564


subject: PR:000012825

subject_name: tissue-type plasminogen activator


subject: PR:000012825


subject: CHEBI:184693

subject_name: GRANISETRON

object_name: malignant glioma


subject: CHEBI:3374

subject_name: Capsaicin

object_name: Central Nervous System Sensitization


subject: CHEBI:3374

object_name: Motor Disorders


subject: UNII:DQY244459T

object_name: Depressed mood


subject: UNII:DQY244459T

object_name: Cancer patients and suicide and depression


subject: UNII:DQY244459T

object_name: Depressed - symptom


subject: UNII:DQY244459T

object_name: Depression, CTCAE


subject: UNII:DQY244459T

object_name: anxiety


subject: UNII:DQY244459T

object_name: anxiety disorder


subject: UNII:DQY244459T

object_name: Anxiety symptoms


subject: UNII:DQY244459T

object_name: Anxiety, CTCAE 3.0


subject: UNII:DQY244459T

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:93775

subject_name: Amethopterin

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: UMLS:C0935889

subject_name: GASTRIMMUNE

object_name: Stomach cancer


subject: UMLS:C0935889

object_name: gastric cancer


subject: UMLS:C0002268

subject_name: alpha-D-galactosidase enzyme

object_name: Postprandial hyperglycemia


subject: UMLS:C0002268

object_name: Normal body mass index


subject: PR:000008009

subject_name: gap junction delta-4 protein

object_name: anal fistula


subject: PR:000008009

object_name: Anal Fistula, CTCAE


subject: UMLS:C5854437

subject_name: XBH 25

object_name: liver carcinoma


subject: UMLS:C5854437

object_name: non-small cell lung carcinoma


subject: UMLS:C5854437

object_name: small cell lung carcinoma


subject: UMLS:C5854437

object_name: melanoma


subject: UMLS:C5554967

subject_name: Oxygen Carrier YQ23

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4727210

subject_name: Cadonilimab

object_name: Advanced cancer


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Locally Advanced Rectal Adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: hepatitis B


subject: CHEBI:92976

subject_name: Latrepirdine

object_name: Huntington disease


subject: CHEBI:92976

object_name: Alzheimer disease


subject: CHEBI:9241

subject_name: Spironolactone

object_name: alcohol abuse


subject: CHEBI:9241

object_name: alcohol dependence


subject: CHEBI:9241

object_name: HIV infection


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: myeloid leukemia


subject: CHEBI:94807

subject_name: Nitazoxanide

object_name: hepatitis C


subject: CHEBI:94807

object_name: chronic hepatitis C virus infection


subject: UNII:T1DQI1B52Y

subject_name: Miransertib

object_name: neoplasm


subject: UNII:T1DQI1B52Y

object_name: Tumor Mass


subject: UNII:T1DQI1B52Y

object_name: Childhood Solid Neoplasm


subject: UNII:T1DQI1B52Y

object_name: Adult Solid Neoplasm


subject: UNII:T1DQI1B52Y

object_name: Solid Neoplasm


subject: UNII:T1DQI1B52Y

object_name: lymphoma


subject: UMLS:C3274586

subject_name: ARQ 092


subject: UMLS:C3274586


subject: UMLS:C3274586


subject: UMLS:C3274586


subject: UMLS:C3274586


subject: UMLS:C3274586


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: castration-resistant prostate carcinoma


subject: UMLS:C1530450

subject_name: AMG 162


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Disorder of intraocular pressure


subject: UNII:2S9ZZM9Q9V

object_name: Intraocular Pressure


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab


subject: UNII:ZL1R02VT79


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Endocrine Breast Diseases


subject: PUBCHEM.COMPOUND:70789204

object_name: breast neoplasm


subject: PUBCHEM.COMPOUND:70789204

object_name: Neoplasm Metastasis


subject: CHEBI:49603

subject_name: Lapatinib


subject: CHEBI:49603


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Fused vertebrae


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UMLS:C4018781

subject_name: human milk preparation

object_name: Dysbiosis


subject: CHEBI:75998

subject_name: Trametinib

object_name: Plasma cell myeloma refractory


subject: CHEBI:75998

object_name: Plasma cell myeloma recurrent


subject: UNII:ZXM835LQ5E

subject_name: Uprosertib


subject: UNII:ZXM835LQ5E


subject: UNII:4EQZ6YO2HI

object_name: non-small cell lung carcinoma


subject: UMLS:C1530450


subject: UMLS:C1660580

subject_name: Vaccine product containing only Neisseria meningitidis conjugated antigen

object_name: meningitis


subject: UMLS:C1660580

object_name: Meningitis, CTCAE


subject: RXCUI:596702

subject_name: Menactra


subject: RXCUI:596702


subject: GTOPDB:12990

subject_name: sintilimab

object_name: anaplastic meningioma


subject: GTOPDB:12990

object_name: grade III meningioma


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: PR:000005627

subject_name: CCHC-type zinc finger nucleic acid binding protein

object_name: neurodegenerative disease


subject: UniProtKB:O42395

subject_name: CNBP_CHICK CCHC-type zinc finger nucleic acid binding protein (sprot)


subject: PR:000004505


subject: PR:000009989

subject_name: lymphocyte antigen 6E


subject: CHEBI:73925

subject_name: His-Asp


subject: UNII:7R9HBZ5P0S


subject: CHEBI:39867

subject_name: Valproic acid

object_name: epilepsy


subject: MESH:C507879

subject_name: cytoflavin

object_name: stroke disorder


subject: MESH:C507879

object_name: cerebrovascular disorder


subject: MESH:C507879

object_name: Stroke (heart beat)


subject: MESH:C507879

object_name: Stroke, CTCAE


subject: CHEBI:17596

subject_name: Inosine


subject: CHEBI:17596


subject: CHEBI:17596


subject: CHEBI:17596


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:17154


subject: CHEBI:17154


subject: CHEBI:17154


subject: CHEBI:57986


subject: CHEBI:57986


subject: CHEBI:57986


subject: CHEBI:57986


subject: UMLS:C3714502

subject_name: Riboflavin Drug Class


subject: UMLS:C3714502


subject: UMLS:C3714502


subject: UMLS:C3714502


subject: CHEBI:17621

subject_name: FMN


subject: CHEBI:17621


subject: CHEBI:17621


subject: CHEBI:17621


subject: CHEBI:17015

subject_name: Riboflavin


subject: CHEBI:17015


subject: CHEBI:17015


subject: CHEBI:17015


subject: CHEBI:15741

subject_name: Succinic acid


subject: CHEBI:15741


subject: CHEBI:15741


subject: CHEBI:15741


subject: UNII:2CN60TN6ZS

subject_name: Lurbinectedin

object_name: Neck Carcinoma


subject: UNII:2CN60TN6ZS


subject: UNII:2CN60TN6ZS

object_name: small cell lung carcinoma


subject: UNII:2CN60TN6ZS

object_name: ovarian cancer


subject: UNII:2CN60TN6ZS

object_name: ovarian neoplasm


subject: UNII:2CN60TN6ZS

object_name: ovarian carcinoma


subject: UNII:2CN60TN6ZS

object_name: Childhood Breast Carcinoma


subject: UNII:2CN60TN6ZS

object_name: breast carcinoma


subject: UNII:2CN60TN6ZS

object_name: breast cancer


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: Drug action (disorder)


subject: UNII:6897GXD6OE

object_name: inflammatory bowel disease


subject: UNII:6897GXD6OE

object_name: Crohn disease


subject: UNII:6897GXD6OE

object_name: ulcerative colitis


subject: UNII:6897GXD6OE

object_name: inflammatory bowel disease 1


subject: CHEBI:7465

subject_name: Naltrexone

object_name: Diabetic Neuralgia


subject: UMLS:C1532737

subject_name: ezetimibe / simvastatin

object_name: myocardial infarction


subject: UMLS:C1532737

object_name: Myocardial Infarction, CTCAE


subject: UMLS:C1532737

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: choroidal neovascularization


subject: CHEBI:41879

object_name: choroidal neovascularization (physical finding)


subject: CHEBI:41879

object_name: age-related macular degeneration


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: testicular germ cell tumor 1


subject: CHEBI:49900

object_name: testicular germ cell tumor


subject: CHEBI:49900

object_name: childhood testicular germ cell tumor


subject: CHEBI:49900

object_name: extragonadal germ cell tumor


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: PUBCHEM.COMPOUND:518740


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: CHEBI:30621


subject: CHEBI:30621


subject: CHEBI:30621


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: CHEBI:119915

subject_name: Fentanyl

object_name: chronic pain (diagnosis)


subject: CHEBI:119915

object_name: Chronic pain


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEBI:8802


subject: GTOPDB:13792

subject_name: iparomlimab

object_name: Metastatic Carcinoma to the Uterine Cervix


subject: GTOPDB:13792

object_name: Cervix carcinoma recurrent


subject: UNII:FN3VWV28BC

subject_name: IPAROMLIMAB


subject: UNII:FN3VWV28BC


subject: UMLS:C5669553

subject_name: Iparomlimab


subject: UMLS:C5669553


subject: GTOPDB:13793

subject_name: tuvonralimab


subject: GTOPDB:13793


subject: UNII:8XWO7LI4LO

subject_name: TUVONRALIMAB


subject: UNII:8XWO7LI4LO


subject: UMLS:C5784793

subject_name: Tuvonralimab


subject: UMLS:C5784793


subject: UMLS:C5206815


subject: UMLS:C5206815


subject: CHEBI:74947

subject_name: Thalidomide

object_name: pancreatic neuroendocrine neoplasm


subject: CHEBI:74947

object_name: pancreatic neuroendocrine tumor


subject: CHEBI:74947

object_name: lung cancer


subject: CHEBI:74947

object_name: lung neoplasm


subject: CHEBI:74947

object_name: lung carcinoma


subject: CHEBI:74947

object_name: Gastrointestinal Carcinoid Tumor


subject: CHEBI:74947

object_name: neoplastic syndrome


subject: CHEBI:74947

object_name: neoplasm


subject: CHEBI:3223

subject_name: Buspirone

object_name: Cervical spinal cord injury


subject: CHEBI:3223

object_name: Tetraparesis


subject: CHEBI:3223

object_name: quadriplegia


subject: CHEBI:8871

subject_name: Risperidone


subject: CHEBI:8871


subject: CHEBI:8871


subject: CHEBI:119915

object_name: Colon Neoplasm


subject: CHEBI:6015

subject_name: Isoflurane


subject: CHEBI:17045

subject_name: Nitrous oxide


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:60802

subject_name: ropivacaine


subject: CHEMBL.COMPOUND:CHEMBL5314814

subject_name: BUDOPRUTUG

object_name: thrombocytopenia due to immune destruction


subject: CHEMBL.COMPOUND:CHEMBL5314814

object_name: autoimmune thrombocytopenic purpura


subject: CHEMBL.COMPOUND:CHEMBL5314814

object_name: monoclonal


subject: UMLS:C5908921

subject_name: Budoprutug


subject: UMLS:C5908921


subject: UMLS:C5908921


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Stress


subject: CHEBI:4466

object_name: type 2 diabetes mellitus


subject: CHEBI:4466

object_name: Diabetes


subject: CHEBI:4466

object_name: diabetes mellitus


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UMLS:C5700426

subject_name: furmonertinib

object_name: non-small cell lung carcinoma


subject: UMLS:C1827106

subject_name: Dipeptidyl-Peptidase IV Inhibitors


subject: UMLS:C1827106

object_name: proteinuria


subject: UMLS:C1827106

object_name: Proteinuria of undiagnosed cause


subject: UMLS:C1827106

object_name: Proteinuria, CTCAE 3.0


subject: UMLS:C1827106

object_name: Proteinuria, CTCAE 5.0


subject: UMLS:C3537161

subject_name: Dipeptidyl Peptidase 4 Inhibitor [EPC]


subject: UMLS:C3537161


subject: UMLS:C3537161


subject: UMLS:C3537161


subject: UMLS:C3537161


subject: CHEBI:29191

subject_name: hydroxyl

object_name: EXCESS LMW-DNA


subject: UMLS:C0700307

subject_name: hydroxyl group


subject: CHEBI:16234

subject_name: Hydroxide ion


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: plantar fasciitis


subject: CHEBI:75275

subject_name: Tetradecyl hydrogen sulfate (ester)

object_name: vein disorder


subject: CHEBI:6931

subject_name: Midazolam

object_name: post operative nausea and vomiting


subject: CHEBI:5494

subject_name: ritropirronium bromide


subject: CHEBI:94449

subject_name: Glycopyrronium


subject: CHEBI:6121

subject_name: Ketamine


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: Childhood Breast Carcinoma


subject: UNII:6XC1PAD3KF

object_name: breast carcinoma


subject: UNII:6XC1PAD3KF

object_name: breast cancer


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: polyp of large intestine


subject: CHEBI:33375

subject_name: Gadolinium

object_name: Acute graft rejection


subject: CHEBI:33375

object_name: Chronic graft rejection


subject: CHEMBL.COMPOUND:CHEMBL1232993

subject_name: GADOLINIUM


subject: CHEMBL.COMPOUND:CHEMBL1232993


subject: UNII:2XLN4Y044H

subject_name: REGADENOSON


subject: UNII:2XLN4Y044H


subject: PUBCHEM.COMPOUND:22451303

subject_name: Regadenoson


subject: PUBCHEM.COMPOUND:22451303


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: Crohn disease


subject: UNII:D733ET3F9O

subject_name: crisantaspase

object_name: acute myeloid leukemia by FAB classification


subject: UNII:D733ET3F9O

object_name: acute myeloid leukemia


subject: UMLS:C0591457

subject_name: Erwinase


subject: UMLS:C0591457


subject: CHEBI:63925

subject_name: PhXa 85

object_name: Glaucoma secondary to other eye disorders


subject: CHEBI:31348

subject_name: Capecitabine

object_name: breast neoplasm


subject: UMLS:C0392938

subject_name: zoledronate


subject: UMLS:C0392938


subject: UMLS:C0392938


subject: UNII:P93RUU11P7

subject_name: INOTUZUMAB

object_name: B-cell neoplasm


subject: UMLS:C1328139


subject: UMLS:C3501753

object_name: Drug toxicity


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: concussion


subject: CHEBI:192614

object_name: Mild Traumatic Brain Injury


subject: CHEBI:192614

object_name: traumatic encephalopathy


subject: CHEBI:192614

object_name: traumatic brain injury


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: UNII:L6WO34R9YG


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: PUBCHEM.COMPOUND:131769997


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: CHEBI:183660


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: UNII:80X7B1F6NW


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: CHEBI:9139


subject: CHEBI:9139


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: rotator cuff syndrome


subject: CHEBI:46195

object_name: Rotator cuff tear


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: CHEBI:41423

subject_name: Celecoxib


subject: CHEBI:41423


subject: CHEBI:49575

subject_name: Diazepam


subject: CHEBI:49575


subject: CHEBI:42797

subject_name: Gabapentin


subject: CHEBI:42797


subject: CHEBI:6129

subject_name: Ketorolac


subject: CHEBI:6129


subject: UNII:2CN60TN6ZS

subject_name: Lurbinectedin

object_name: lung cancer


subject: UNII:2CN60TN6ZS

object_name: lung neoplasm


subject: UNII:2CN60TN6ZS

object_name: lung carcinoma


subject: CHEBI:231087

subject_name: Trilaciclib


subject: CHEBI:231087


subject: CHEBI:231087


subject: CHEBI:66889

subject_name: Peginesatide

object_name: chronic kidney disease


subject: CHEBI:66889

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:66889

object_name: end stage renal failure


subject: CHEBI:66889

object_name: Chronic uremia


subject: CHEBI:66889

object_name: anemia


subject: CHEBI:66889

object_name: Anemia, CTCAE


subject: UMLS:C1710272

subject_name: hematide


subject: UMLS:C1710272


subject: UMLS:C1710272


subject: UMLS:C1710272


subject: UMLS:C1710272


subject: UMLS:C1710272


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Locally Advanced Lung Non-Small Cell Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Non-small cell lung cancer recurrent


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Lung Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVB Lung Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Lung Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVA Lung Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIA Lung Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIC Lung Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IIIB Lung Cancer AJCC v8


subject: UNII:3DGD69C6PV

subject_name: brigatinib


subject: UNII:3DGD69C6PV


subject: UNII:3DGD69C6PV


subject: UNII:3DGD69C6PV


subject: UNII:3DGD69C6PV


subject: UNII:3DGD69C6PV


subject: UNII:3DGD69C6PV


subject: UNII:3DGD69C6PV


subject: UNII:3DGD69C6PV


subject: UNII:3DGD69C6PV


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:45863

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:90227

subject_name: Selumetinib


subject: CHEBI:90227


subject: UNII:9013DUQ28K

subject_name: Anakinra

object_name: Corneal pannus


subject: UMLS:C1704264

subject_name: Interleukin 1 Receptor Antagonist Protein


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: CHEBI:87647

subject_name: tolonium chloride

object_name: Root canal infection


subject: CHEBI:74705

subject_name: Met-Leu


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: Recurrent lower respiratory tract infections


subject: UNII:7PR4P7YOKT

object_name: HIV infection


subject: UMLS:C4761646

subject_name: HIV Integrase Inhibitor


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: diffuse large B-cell lymphoma


subject: CHEBI:173077


subject: UNII:A3N5ZCN45C

subject_name: Smectite

object_name: diarrhea


subject: UNII:A3N5ZCN45C

object_name: rectal discharge diarrhea (physical finding)


subject: UNII:A3N5ZCN45C

object_name: Diarrhea, CTCAE


subject: UMLS:C0074690


subject: UMLS:C0074690


subject: UMLS:C0074690


subject: UMLS:C5445313

subject_name: Corn starch antigen

object_name: hypertension


subject: UMLS:C5445313

object_name: Hypertension, CTCAE


subject: DRUGBANK:DB11599

subject_name: Starch, corn


subject: DRUGBANK:DB11599


subject: UNII:43A5P87Z4T

object_name: Solid Neoplasm


subject: UMLS:C3272654


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: Unresectable Hepatocellular Carcinoma


subject: CHEBI:68647

subject_name: Regorafenib


subject: GTOPDB:12990

subject_name: sintilimab


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: Mixed delirium


subject: CHEBI:168243

object_name: Hyperactive delirium


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: UMLS:C0751626

subject_name: Zyban

object_name: nicotine dependence


subject: UMLS:C0751626

object_name: Tabagism


subject: UMLS:C0751626

object_name: Dependence


subject: UMLS:C0751626

object_name: Harmful pattern of substance use


subject: UMLS:C0751626

object_name: substance abuse


subject: CHEBI:3219

subject_name: Bupropion


subject: CHEBI:3219


subject: CHEBI:3219


subject: CHEBI:3219


subject: UMLS:C4053602

subject_name: Anti-IL-4/IL-13 Combination Agent QBX258

object_name: Childhood Breast Carcinoma


subject: UMLS:C4053602

object_name: breast carcinoma


subject: UMLS:C4053602

object_name: breast cancer


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: hyperlipidemia


subject: UNII:LKC0U3A8NJ

object_name: hyperlipoproteinemia


subject: UNII:LKC0U3A8NJ

object_name: Hyperlipidemia, CTCAE


subject: UNII:LKC0U3A8NJ

object_name: Serum lipids high (finding)


subject: UNII:H4C81M8YYW

object_name: Cannabis use disorder


subject: CHEBI:3011

subject_name: Benazepril

object_name: type 2 diabetes mellitus


subject: CHEBI:3011

object_name: Diabetes


subject: CHEBI:3011

object_name: diabetes mellitus


subject: CHEBI:9927

subject_name: Valsartan


subject: CHEBI:9927


subject: UMLS:C3489797

object_name: chronic obstructive pulmonary disease


subject: CHEBI:23359

subject_name: colchicine

object_name: Inflammation


subject: CHEBI:23359


subject: CHEBI:23359

object_name: Insulin resistance


subject: CHEBI:23359

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:23359

object_name: obesity


subject: CHEBI:23359

object_name: Obesity, CTCAE


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: neurotrophic keratopathy


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:8805

subject_name: Repaglinide


subject: CHEBI:8805


subject: CHEBI:8805


subject: CHEBI:136052

subject_name: Lobeglitazone


subject: UMLS:C2744791

subject_name: CKD 501


subject: CHEBI:47519

subject_name: Ketoconazole


subject: UMLS:C4288268

subject_name: Ruxolitinib Phosphate Cream

object_name: psoriasis


subject: UNII:73B0K5S26A

subject_name: Belimumab

object_name: EXCESS LMW-DNA


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Pregnant


subject: PUBCHEM.COMPOUND:2735

object_name: gingival and periodontal disease


subject: PUBCHEM.COMPOUND:2735

object_name: Deficiency of vitamin D3


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:177770

subject_name: Ganetespib

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:177770

object_name: recurrent primary peritoneal cavity cancer


subject: CHEBI:177770

object_name: Recurrent ovarian cancer


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:77260

subject_name: Omeprazole


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: anus cancer


subject: UNII:M89N0Q7EQR

object_name: anal carcinoma


subject: UNII:M89N0Q7EQR

object_name: cervical cancer


subject: UNII:M89N0Q7EQR

object_name: cervical carcinoma


subject: UNII:M89N0Q7EQR

object_name: vaginal cancer


subject: UNII:M89N0Q7EQR

object_name: vaginal carcinoma


subject: UNII:M89N0Q7EQR

object_name: Adult Penile Carcinoma


subject: UNII:M89N0Q7EQR

object_name: penis carcinoma


subject: UNII:M89N0Q7EQR

object_name: penile cancer


subject: UNII:M89N0Q7EQR

object_name: oropharyngeal carcinoma


subject: UNII:M89N0Q7EQR

object_name: oropharynx cancer


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: UMLS:C5395863

subject_name: Vaccine product containing only inactivated whole Rabies lyssavirus antigen

object_name: rabies


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: osteoarthritis, knee


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEBI:5523

subject_name: Goserelin

object_name: Childhood Breast Carcinoma


subject: CHEBI:5523

object_name: breast carcinoma


subject: CHEBI:5523

object_name: breast cancer


subject: CHEBI:74947

subject_name: Thalidomide

object_name: heart failure


subject: CHEBI:74947

object_name: congestive heart failure


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: Secondary malignant neoplasm of lung


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Dravet syndrome


subject: PUBCHEM.COMPOUND:521372

object_name: developmental and epileptic encephalopathy, 6A


subject: PUBCHEM.COMPOUND:521372

object_name: Lennox-Gastaut syndrome


subject: CHEBI:31270

subject_name: beraprost sodium

object_name: diabetic kidney disease


subject: PUBCHEM.COMPOUND:2352

subject_name: beraprost


subject: UMLS:C0526064


subject: UMLS:C5847498

subject_name: Irinotecan liposome injection

object_name: Advanced breast cancer


subject: CHEBI:80630

subject_name: Irinotecan


subject: UMLS:C4053664

object_name: ovarian cancer


subject: UMLS:C4053664

object_name: ovarian neoplasm


subject: UMLS:C4053664

object_name: ovarian carcinoma


subject: CHEBI:229225

subject_name: Bexagliflozin

object_name: type 2 diabetes mellitus


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Ambulatory Status - Mastectomy


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:47381

subject_name: Diclofenac

object_name: Pain Relief


subject: CHEBI:62088

subject_name: Metamizole


subject: CHEBI:75722

subject_name: Tramadol


subject: CHEBI:7789

subject_name: Orphenadrine


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: inflammatory breast carcinoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: CHEBI:47898

subject_name: Epirubicin


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:28661

subject_name: Gamolenic acid

object_name: Body-Weight Trajectory


subject: UMLS:C5834103

subject_name: PIKA rabies vaccine

object_name: rabies


subject: UMLS:C5834103

object_name: Prevention problem


subject: CHEBI:10023

subject_name: Voriconazole

object_name: Cryptococcal meningitis


subject: CHEBI:10023

object_name: AIDS


subject: PUBCHEM.COMPOUND:23668620

subject_name: amphotericin B, deoxycholate drug combination


subject: PUBCHEM.COMPOUND:23668620


subject: UNII:44WG8E9MTU

subject_name: AMPHOTERICIN B DEOXYCHOLATE


subject: UNII:44WG8E9MTU


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:73604


subject: CHEBI:16919

subject_name: Creatine

object_name: spinal cord injury


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: asthma


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL


subject: UMLS:C5201274

subject_name: Ascorbate Injection

object_name: Increased reactive oxygen species production


subject: UMLS:C5201274

object_name: Reperfusion Injury


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Disseminated Malignant Neoplasm


subject: UNII:2S9ZZM9Q9V

object_name: Embolism, Tumor


subject: UNII:2S9ZZM9Q9V

object_name: Neoplasm Metastasis


subject: UNII:2S9ZZM9Q9V

object_name: colorectal adenocarcinoma


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: opiate dependence


subject: PUBCHEM.COMPOUND:521372

object_name: heroin abuse


subject: PUBCHEM.COMPOUND:521372

object_name: substance-related disorder


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:39585


subject: CHEBI:39585


subject: PUBCHEM.COMPOUND:152165

object_name: Post-Operative Pain


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:9927

subject_name: Valsartan

object_name: aortic valve disease 2


subject: CHEBI:9927

object_name: aortic stenosis


subject: CHEBI:9927

object_name: aortic valve disease 3


subject: CHEBI:9927

object_name: Stenosis of aorta


subject: CHEBI:9927

object_name: Left ventricular hypertrophy


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Non-Hodgkin's lymphoma refractory


subject: UNII:DPT0O3T46P

object_name: T-cell lymphoma refractory


subject: UNII:DPT0O3T46P

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UNII:DPT0O3T46P

object_name: T-cell lymphoma recurrent


subject: UNII:DPT0O3T46P

object_name: Refractory Aggressive Non-Hodgkin Lymphoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Aggressive Adult Non-Hodgkin Lymphoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Aggressive Non-Hodgkin Lymphoma


subject: UNII:DPT0O3T46P

object_name: Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma


subject: UNII:DPT0O3T46P

object_name: Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma


subject: UNII:DPT0O3T46P

object_name: primary mediastinal large B-cell lymphoma


subject: UMLS:C3537265

subject_name: LY573636 sodium

object_name: Solid Neoplasm


subject: CHEBI:20993

subject_name: GLUCOSAMINE

object_name: osteoarthritis, knee


subject: CHEBI:28393

subject_name: D-glucosamine


subject: PUBCHEM.COMPOUND:152165

object_name: Renal Colic, CTCAE


subject: PUBCHEM.COMPOUND:152165

object_name: renal colic


subject: PUBCHEM.COMPOUND:152165

object_name: Urinary Calculi


subject: CHEBI:47381


subject: CHEBI:47381


subject: CHEBI:47381


subject: UNII:Q60AU1LLNU

subject_name: OGLUFANIDE DISODIUM

object_name: ovarian cancer


subject: UNII:Q60AU1LLNU

object_name: ovarian neoplasm


subject: UNII:Q60AU1LLNU

object_name: ovarian carcinoma


subject: UMLS:C0076603

subject_name: thymogen


subject: UMLS:C0076603


subject: UMLS:C0076603


subject: UNII:2N4O9L084N

subject_name: Nabilone

object_name: Parkinson disease


subject: UNII:73SM5SF3OR

subject_name: Abrocitinib

object_name: granuloma annulare


subject: CHEMBL.COMPOUND:CHEMBL2109401


subject: UMLS:C3640798


subject: CHEBI:64816

object_name: pleural mesothelioma


subject: CHEBI:64816

object_name: malignant pleural mesothelioma


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: UNII:XRO4566Q4R

subject_name: INTERFERON BETA

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:136053

subject_name: Nemonoxacin

object_name: Community-Acquired Pneumonia


subject: UMLS:C2742588


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: Metastatic cholangiocarcinoma


subject: PUBCHEM.COMPOUND:156963654

object_name: Cholangiocarcinoma recurrent


subject: PUBCHEM.COMPOUND:156963654

object_name: Locally Advanced Cholangiocarcinoma


subject: PUBCHEM.COMPOUND:156963654

object_name: Stage IV Intrahepatic Cholangiocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:156963654

object_name: Stage III Intrahepatic Cholangiocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:156963654

object_name: Stage IV Hilar Cholangiocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:156963654

object_name: Stage III Hilar Cholangiocarcinoma AJCC v8


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: UNII:3S9RX35S5X

subject_name: Fimepinostat

object_name: Solid Neoplasm


subject: UNII:3S9RX35S5X

object_name: triple-negative breast carcinoma


subject: UNII:3S9RX35S5X

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:3S9RX35S5X

object_name: NUT Carcinoma


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: alcohol abuse


subject: PUBCHEM.COMPOUND:54675783

object_name: alcohol dependence


subject: PUBCHEM.COMPOUND:54675783

object_name: Cognitive impairment


subject: PUBCHEM.COMPOUND:54675783

object_name: Inflammation


subject: PUBCHEM.COMPOUND:54675783

object_name: Craving


subject: PUBCHEM.COMPOUND:23667621

subject_name: DEXAMETHASONE SODIUM PHOSPHATE

object_name: Leg Injuries


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:4672

subject_name: Docetaxel

object_name: anal canal carcinoma


subject: CHEBI:4672

object_name: cloacogenic carcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:63629

subject_name: Tizanidine

object_name: Inguinal hernia, unilateral


subject: UMLS:C5888303

object_name: prostate carcinoma


subject: UMLS:C5888303

object_name: prostate cancer


subject: DRUGBANK:DB18803

subject_name: Technetium TC-99M trofolastat


subject: DRUGBANK:DB18803


subject: UMLS:C3854029

subject_name: antiseptics ethanol


subject: UMLS:C3854029

object_name: Drug action (disorder)


subject: UMLS:C3854030

subject_name: CNS depressants ethanol


subject: UMLS:C3854030


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:16236


subject: UMLS:C5206587

subject_name: MetAP2 Inhibitor APL-1202

object_name: bladder tumor


subject: UMLS:C5206587

object_name: urinary bladder carcinoma


subject: UMLS:C5206587

object_name: urinary bladder cancer


subject: UMLS:C5206587

object_name: childhood bladder carcinoma


subject: CHEBI:31348

subject_name: Capecitabine

object_name: gastric neoplasm


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: MESH:C478242

subject_name: vaxigrip

object_name: influenza


subject: MESH:C000634027

object_name: neurodegeneration with brain iron accumulation 2A


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Stage IIB Anal Cancer AJCC v8


subject: CHEBI:231614

object_name: Stage III Anal Cancer AJCC v8


subject: CHEBI:231614


subject: CHEBI:231614

object_name: anal margin squamous cell carcinoma


subject: CHEBI:231614

object_name: anus basaloid carcinoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:14907381

object_name: Neck Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:14907381

object_name: head and neck cancer


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: UNII:EXT215F4ZU

subject_name: DEGARELIX ACETATE

object_name: prostate carcinoma


subject: UNII:EXT215F4ZU

object_name: prostate cancer


subject: UNII:I18S89P20R


subject: UNII:I18S89P20R


subject: UMLS:C2718533

subject_name: Gonax


subject: UMLS:C2718533


subject: CHEBI:8093

subject_name: Phenylephrine

object_name: telogen effluvium


subject: UMLS:C0358182

subject_name: Loceryl nail lacquer

object_name: Foot Dermatoses


subject: PUBCHEM.COMPOUND:2269

object_name: yaws


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Childhood Breast Carcinoma


subject: CHEBI:114785

object_name: breast carcinoma


subject: CHEBI:114785

object_name: breast cancer


subject: CHEBI:6904

subject_name: Metoprolol

object_name: Premature infant


subject: CHEBI:192614

subject_name: Homosildenafil


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: skin squamous cell carcinoma


subject: UNII:PQX0D8J21J

object_name: Secondary malignant neoplasm of skin


subject: UNII:PQX0D8J21J

object_name: Carcinoma Metastatic to the Skin


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Metastatic Malignancy


subject: UMLS:C3827082


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB


subject: UMLS:C4331912


subject: CHEMBL.COMPOUND:CHEMBL4297877

subject_name: BALSTILIMAB

object_name: glioblastoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Brain Stem Glioblastoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: glioma susceptibility 1


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Adult Gliosarcoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: gliosarcoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Childhood Gliosarcoma


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: CHEMBL.COMPOUND:CHEMBL4650435

subject_name: BOTENSILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: UMLS:C4764272

subject_name: Botensilimab


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:63613

subject_name: Nevirapine

object_name: Pregnant


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: prostate carcinoma


subject: UNII:5TAA004E22

object_name: prostate cancer


subject: PR:000005931


subject: PR:000005931


subject: CHEBI:74947

subject_name: Thalidomide


subject: CHEBI:74947


subject: UNII:2QN49PWH71

subject_name: benzylmandelate

object_name: schizophrenia


subject: PUBCHEM.COMPOUND:5284632

subject_name: Trospium


subject: CHEBI:114785

subject_name: Erlotinib


subject: CHEBI:114785


subject: UNII:Z4HZ70S62Q

subject_name: Unesbulin

object_name: leiomyosarcoma


subject: UNII:Z4HZ70S62Q

object_name: Childhood Leiomyosarcoma


subject: UNII:Z4HZ70S62Q

object_name: Adult Leiomyosarcoma


subject: CHEBI:141530

subject_name: Delanzomib

object_name: plasma cell myeloma


subject: UMLS:C2352802


subject: UNII:19HY34R6UN

object_name: Advanced cancer


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:600103

subject_name: daptomycin

object_name: Fever


subject: CHEBI:600103

object_name: Fever symptoms (finding)


subject: CHEBI:600103

object_name: Fever, CTCAE


subject: CHEBI:600103

object_name: Infection


subject: CHEBI:600103

object_name: infectious disease


subject: CHEBI:600103

object_name: Adverse Event Associated with Infection


subject: CHEBI:600103

object_name: leukopenia


subject: CHEBI:600103

object_name: neutropenia


subject: CHEBI:600103

object_name: Hyperhidrosis


subject: CHEBI:600103

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:600103

object_name: Hot Flashes, CTCAE


subject: CHEBI:600103

object_name: Hot flashes


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Allergy


subject: CHEBI:73604

object_name: hypersensitivity reaction disease


subject: CHEBI:73604

object_name: Emotional hypersensitivity


subject: CHEBI:2704

subject_name: Anastrozole

object_name: breast neoplasm


subject: CHEBI:4953

subject_name: Exemestane


subject: CHEBI:6427

subject_name: Leuprolide


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab


subject: UNII:MJ4PTD2VVW

subject_name: GALANTAMINE HYDROBROMIDE

object_name: vascular dementia


subject: UNII:MJ4PTD2VVW

object_name: Alzheimer disease type 1


subject: UNII:MJ4PTD2VVW

object_name: Alzheimer disease


subject: CHEBI:42944

subject_name: Galantamine


subject: CHEBI:42944


subject: CHEBI:42944


subject: UMLS:C2095490

subject_name: corticosteroid injection

object_name: Postoperative Pain, Acute


subject: UMLS:C2348252

subject_name: Diclofenac Sodium Gel


subject: CHEBI:6129

subject_name: Ketorolac


subject: CHEBI:18216

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:20057296

subject_name: Ganglioside GM1 (18:1/16:0)


subject: PUBCHEM.COMPOUND:20057300


subject: CHEBI:177678

subject_name: Ganglioside GM1 (18:1/12:0)


subject: PUBCHEM.COMPOUND:20057297

subject_name: Sygen


subject: PUBCHEM.COMPOUND:20057299

subject_name: Ganglioside GM1 (18:1/22:0)


subject: PUBCHEM.COMPOUND:20057301


subject: CHEBI:177701

subject_name: Ganglioside GM1 (18:1/9Z-18:1)


subject: PUBCHEM.COMPOUND:20057303

subject_name: Ganglioside GM1 (d18:1/24:0)


subject: CHEBI:73110

subject_name: ganglioside GM1(1-)


subject: CHEBI:61048

subject_name: Ganglioside GM1


subject: PUBCHEM.COMPOUND:20057298

subject_name: Ganglioside GM1 (18:1/20:0)


subject: PUBCHEM.COMPOUND:22833613

subject_name: Ganglioside GM1 (d18:1/25:0)


subject: PUBCHEM.COMPOUND:20057302

subject_name: Ganglioside GM1 (d18:1/26:0)


subject: UMLS:C0885467

subject_name: Juglans regia preparation

object_name: Asthenozoospermia


subject: UMLS:C0885467

object_name: Reduced sperm motility


subject: UMLS:C0885467

object_name: Abnormal sperm morphology


subject: UMLS:C0885467

object_name: oligospermia


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: pervasive developmental disorder


subject: CHEBI:4466

object_name: autism


subject: CHEBI:4466

object_name: autism spectrum disorder


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: Stomach cancer


subject: PUBCHEM.COMPOUND:6096882

object_name: gastric cancer


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UMLS:C2987383


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Lack of Expression of PD-L1


subject: UNII:DPT0O3T46P

object_name: malignant mesothelioma


subject: UNII:DPT0O3T46P

object_name: Progressive cGVHD


subject: UNII:DPT0O3T46P

object_name: Progressive Disease


subject: UNII:DPT0O3T46P

object_name: Progressive Neoplastic Disease


subject: UNII:DPT0O3T46P

object_name: IMWG Progressive Disease


subject: UNII:DPT0O3T46P

object_name: irPD (Immune-Related Response Criteria)


subject: UNII:DPT0O3T46P

object_name: Global Progressive Disease in Viscera


subject: UNII:DPT0O3T46P

object_name: RECIL PD


subject: UNII:DPT0O3T46P

object_name: Global Progressive Disease in Skin


subject: UNII:DPT0O3T46P

object_name: Global Progressive Disease


subject: UNII:DPT0O3T46P

object_name: Global Progressive Disease in Lymph Nodes


subject: UNII:DPT0O3T46P

object_name: Global Progressive Disease in Blood


subject: CHEBI:35854

subject_name: Valaciclovir

object_name: Acute apical abscess


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Advanced Urothelial Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Metastatic urothelial carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Unresectable Urothelial Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Urothelial carcinoma ureter metastatic


subject: UNII:2S9ZZM9Q9V

object_name: Metastatic Bladder Urothelial Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Metastatic Urethral Urothelial Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Metastatic Renal Pelvis Urothelial Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Bladder transitional cell carcinoma stage IV


subject: UNII:2S9ZZM9Q9V

object_name: metastatic prostate carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Urethral Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Ureter Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Renal Pelvis Cancer AJCC v7


subject: CHEBI:84363

object_name: coronary microvascular disorder


subject: CHEBI:2376

subject_name: acarbose


subject: CHEBI:135285

subject_name: Vildagliptin


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: smoldering plasma cell myeloma


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:28876

subject_name: Melphalan


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib


subject: UMLS:C1709429


subject: GTOPDB:13716

subject_name: disitamab vedotin

object_name: Childhood Breast Carcinoma


subject: GTOPDB:13716

object_name: breast carcinoma


subject: GTOPDB:13716

object_name: breast cancer


subject: UNII:RB3U3A1S27

subject_name: DISITAMAB VEDOTIN


subject: UNII:RB3U3A1S27


subject: UNII:RB3U3A1S27


subject: UMLS:C4329329


subject: UMLS:C4329329


subject: UMLS:C4329329


subject: UMLS:C1541784

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:64153

subject_name: Tanespimycin


subject: CHEBI:93755


subject: CHEBI:31401

subject_name: Cilostazol

object_name: type 2 diabetes mellitus


subject: UMLS:C5706416

subject_name: IL-2 Superkine-Recombinant Human Albumin Fusion Protein MDNA11

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5706416

object_name: Childhood Solid Neoplasm


subject: UMLS:C5706416

object_name: Adult Solid Neoplasm


subject: UMLS:C5706416

object_name: Solid Neoplasm


subject: UMLS:C5706416

object_name: Unresectable Solid Neoplasm


subject: UMLS:C5706416

object_name: Microsatellite instability-high solid malignant tumor


subject: UMLS:C5706416

object_name: Cancer with a high tumour mutational burden


subject: UMLS:C5706416

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5706416

object_name: non-small cell squamous lung carcinoma


subject: UMLS:C5706416

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5706416

object_name: clear cell renal carcinoma


subject: UMLS:C5706416

object_name: skin squamous cell carcinoma


subject: UMLS:C5706416

object_name: cutaneous squamous cell carcinoma


subject: UMLS:C5706416

object_name: triple-negative breast carcinoma


subject: UMLS:C5706416

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5706416

object_name: ovarian carcinoma


subject: UMLS:C5706416

object_name: primary peritoneal carcinoma


subject: UMLS:C5706416

object_name: Primary Peritoneal Cancer


subject: UMLS:C5706416

object_name: Microsatellite instability-high colorectal cancer


subject: UMLS:C5706416

object_name: fallopian tube carcinoma


subject: UMLS:C5706416

object_name: fallopian tube cancer


subject: UMLS:C5706416

object_name: pleural mesothelioma


subject: UMLS:C5706416

object_name: malignant pleural mesothelioma


subject: UMLS:C5706416

object_name: trabecular adenocarcinoma


subject: UMLS:C5706416

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C5706416

object_name: endometrial carcinoma


subject: UMLS:C5706416

object_name: endometrial cancer


subject: UMLS:C5706416

object_name: uterine corpus cancer


subject: UMLS:C5706416

object_name: skin neoplasm


subject: UMLS:C5706416

object_name: skin cancer


subject: UMLS:C5706416

object_name: basal cell carcinoma


subject: UMLS:C5706416

object_name: skin basal cell carcinoma


subject: UMLS:C5706416

object_name: carcinoma of esophagus


subject: UMLS:C5706416

object_name: esophageal cancer


subject: UMLS:C5706416

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5706416

object_name: neoplasm of esophagus


subject: UMLS:C5706416

object_name: cervical cancer


subject: UMLS:C5706416

object_name: melanoma


subject: UMLS:C5706416

object_name: skin melanoma


subject: UMLS:C5706416

object_name: cervical carcinoma


subject: UMLS:C5706416

object_name: bladder tumor


subject: UMLS:C5706416

object_name: urinary bladder carcinoma


subject: UMLS:C5706416

object_name: urinary bladder cancer


subject: UMLS:C5706416

object_name: childhood bladder carcinoma


subject: UMLS:C5706416

object_name: ovarian cancer


subject: UMLS:C5706416

object_name: ovarian neoplasm


subject: UMLS:C5706416

object_name: Stomach cancer


subject: UMLS:C5706416

object_name: gastric cancer


subject: UMLS:C5706416

object_name: mucosal melanoma


subject: UMLS:C5706416

object_name: acral lentiginous melanoma


subject: UMLS:C5706416

object_name: Acral Melanoma


subject: UNII:DPT0O3T46P

object_name: Microsatellite instability-high solid malignant tumor


subject: UNII:DPT0O3T46P

object_name: Cancer with a high tumour mutational burden


subject: UNII:DPT0O3T46P

object_name: non-small cell squamous lung carcinoma


subject: UNII:DPT0O3T46P

object_name: primary peritoneal carcinoma


subject: UNII:DPT0O3T46P

object_name: Primary Peritoneal Cancer


subject: UNII:DPT0O3T46P

object_name: Microsatellite instability-high colorectal cancer


subject: UNII:DPT0O3T46P

object_name: fallopian tube carcinoma


subject: UNII:DPT0O3T46P

object_name: fallopian tube cancer


subject: UNII:DPT0O3T46P

object_name: pleural mesothelioma


subject: UNII:DPT0O3T46P

object_name: malignant pleural mesothelioma


subject: UNII:DPT0O3T46P

object_name: trabecular adenocarcinoma


subject: UNII:DPT0O3T46P

object_name: cutaneous neuroendocrine carcinoma


subject: UNII:DPT0O3T46P

object_name: endometrial carcinoma


subject: UNII:DPT0O3T46P

object_name: endometrial cancer


subject: UNII:DPT0O3T46P

object_name: uterine corpus cancer


subject: UNII:DPT0O3T46P

object_name: skin neoplasm


subject: UNII:DPT0O3T46P

object_name: skin cancer


subject: UNII:DPT0O3T46P

object_name: basal cell carcinoma


subject: UNII:DPT0O3T46P

object_name: skin basal cell carcinoma


subject: UNII:DPT0O3T46P

object_name: cervical cancer


subject: UNII:DPT0O3T46P

object_name: skin melanoma


subject: UNII:DPT0O3T46P

object_name: cervical carcinoma


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: B-cell chronic lymphocytic leukemia


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: UNII:S7V92P67HO


subject: UNII:90ZX3Q3FR7

subject_name: Risankizumab

object_name: Chronic small plaque psoriasis


subject: UMLS:C4078397


subject: CHEBI:87631

subject_name: statin

object_name: liver carcinoma


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:145371

subject_name: Binimetinib

object_name: lung cancer


subject: CHEBI:145371

object_name: lung neoplasm


subject: CHEBI:145371

object_name: lung carcinoma


subject: CHEBI:145371

object_name: ALK Gene Translocation


subject: CHEBI:145371

object_name: ROS1 gene rearrangement


subject: CHEBI:145371

object_name: Recurrent Carcinoma


subject: CHEBI:145371

object_name: refractory malignant neoplasm


subject: CHEBI:145371

object_name: MET gene amplification


subject: CHEBI:77562

subject_name: rac-crizotinib


subject: CHEBI:77562


subject: CHEBI:77562


subject: CHEBI:77562


subject: CHEBI:77562


subject: CHEBI:77562


subject: CHEBI:77562


subject: CHEBI:77562


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: PUBCHEM.COMPOUND:78162481

subject_name: Lorlatinib


subject: PUBCHEM.COMPOUND:78162481


subject: PUBCHEM.COMPOUND:78162481


subject: PUBCHEM.COMPOUND:78162481


subject: PUBCHEM.COMPOUND:78162481


subject: PUBCHEM.COMPOUND:78162481


subject: PUBCHEM.COMPOUND:78162481


subject: PUBCHEM.COMPOUND:78162481


subject: UMLS:C4528574

subject_name: PTPN11 inhibitor TNO155


subject: UMLS:C4528574


subject: UMLS:C4528574


subject: UMLS:C4528574


subject: UMLS:C4528574


subject: UMLS:C4528574


subject: UMLS:C4528574


subject: UMLS:C4528574


subject: UMLS:C4528574

object_name: non-small cell lung carcinoma


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: paroxysmal nocturnal hemoglobinuria


subject: CHEBI:15765

subject_name: Levodopa

object_name: Parkinson disease


subject: CHEBI:176724

subject_name: Etiracetam

object_name: focal epilepsy


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: UNII:8L7891MRB6

subject_name: Encorafenib


subject: UMLS:C5418007

subject_name: SEA TGT


subject: UNII:LZZ0IC2EWP

subject_name: SASANLIMAB


subject: UMLS:C4505505

object_name: diabetes mellitus


subject: UMLS:C4505505

object_name: neuropathy, small fiber


subject: UMLS:C4505505

object_name: primary erythermalgia


subject: PUBCHEM.COMPOUND:11963629

subject_name: ferryl iron

object_name: cardiovascular disorder


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Carcinoma breast stage IV


subject: CHEBI:31348

object_name: estrogen-receptor positive breast cancer


subject: CHEBI:31348

object_name: Metastatic HER2-Negative Breast Carcinoma


subject: CHEBI:31348

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:5959

subject_name: Irbesartan

object_name: hypertension


subject: CHEBI:5959

object_name: Hypertension, CTCAE


subject: CHEBI:47612

subject_name: Bezafibrate

object_name: type 2 diabetes mellitus


subject: CHEBI:39669

subject_name: Diflunisal


subject: UNII:3H8GSZ4SQL

subject_name: Avatrombopag

object_name: Chemotherapy-Induced Thrombocytopenia


subject: UNII:3H8GSZ4SQL

object_name: digestive system cancer


subject: UNII:3H8GSZ4SQL

object_name: digestive system neoplasm


subject: UNII:3H8GSZ4SQL

object_name: Neoplasm of the gastrointestinal tract


subject: MESH:D000082082

subject_name: Immune Checkpoint Inhibitors

object_name: liver carcinoma


subject: MESH:D000082082

object_name: Klatskin Tumor


subject: GTOPDB:7988

subject_name: nimotuzumab


subject: GTOPDB:7988


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: UNII:71492GE1FX

subject_name: Benralizumab

object_name: Nasal Polyp


subject: UNII:71492GE1FX

object_name: Eosinophilic disorder


subject: UNII:71492GE1FX

object_name: Eosinophilia


subject: UNII:71492GE1FX

object_name: Eosinophilia, CTCAE


subject: UNII:71492GE1FX

object_name: chronic rhinosinusitis


subject: CHEBI:63610

subject_name: Misoprostol

object_name: cesarean section; complications


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Stage III Laryngeal Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage III Lip and Oral Cavity Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IVB Laryngeal Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IVA Laryngeal Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IVB Lip and Oral Cavity Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IVA Lip and Oral Cavity Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UNII:28X28X9OKV

object_name: Squamous Cell Carcinoma of Unknown Primary


subject: UNII:28X28X9OKV

object_name: Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UNII:28X28X9OKV

object_name: hypopharynx squamous cell carcinoma


subject: UNII:28X28X9OKV

object_name: Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UNII:28X28X9OKV

object_name: oropharynx squamous cell carcinoma


subject: UNII:28X28X9OKV

object_name: Stage III Hypopharyngeal Carcinoma AJCC v8


subject: UNII:28X28X9OKV

object_name: oral cavity squamous cell carcinoma


subject: UNII:28X28X9OKV

object_name: Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UNII:28X28X9OKV

object_name: laryngeal squamous cell carcinoma


subject: UNII:28X28X9OKV

object_name: Stage IVA Hypopharyngeal Carcinoma AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IVB Hypopharyngeal Carcinoma AJCC v8


subject: UMLS:C3641122

object_name: Stage III Laryngeal Cancer AJCC v8


subject: UMLS:C3641122

object_name: Stage III Lip and Oral Cavity Cancer AJCC v8


subject: UMLS:C3641122

object_name: Stage IVB Laryngeal Cancer AJCC v8


subject: UMLS:C3641122

object_name: Stage IVA Laryngeal Cancer AJCC v8


subject: UMLS:C3641122

object_name: Stage IVB Lip and Oral Cavity Cancer AJCC v8


subject: UMLS:C3641122

object_name: Stage IVA Lip and Oral Cavity Cancer AJCC v8


subject: UMLS:C3641122

object_name: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UMLS:C3641122

object_name: Squamous Cell Carcinoma of Unknown Primary


subject: UMLS:C3641122

object_name: Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UMLS:C3641122

object_name: Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UMLS:C3641122

object_name: hypopharynx squamous cell carcinoma


subject: UMLS:C3641122

object_name: Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UMLS:C3641122

object_name: oropharynx squamous cell carcinoma


subject: UMLS:C3641122

object_name: Stage III Hypopharyngeal Carcinoma AJCC v8


subject: UMLS:C3641122

object_name: oral cavity squamous cell carcinoma


subject: UMLS:C3641122

object_name: Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UMLS:C3641122

object_name: laryngeal squamous cell carcinoma


subject: UMLS:C3641122

object_name: Stage IVA Hypopharyngeal Carcinoma AJCC v8


subject: UMLS:C3641122

object_name: Stage IVB Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:16664

subject_name: Albendazole

object_name: cysticercosis


subject: CHEBI:16664

object_name: Neurocysticercosis


subject: CHEBI:16664

object_name: Central Nervous System Cysticercosis


subject: UNII:2P6O7CFW5K

subject_name: Triheptanoin

object_name: glycogen storage disease III


subject: UNII:2P6O7CFW5K

object_name: glycogen storage disease XV


subject: UNII:2P6O7CFW5K

object_name: glycogen storage disease VII


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: myocardial infarction


subject: CHEBI:8228

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:8228

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: benign urinary system neoplasm


subject: CHEBI:175901

object_name: urinary system neoplasm


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: post-traumatic stress disorder


subject: PUBCHEM.COMPOUND:54214995

subject_name: Sacubitril

object_name: heart failure


subject: PUBCHEM.COMPOUND:54214995

object_name: Heart Failure, CTCAE


subject: PUBCHEM.COMPOUND:54214995

object_name: Chagas disease


subject: CHEBI:9927

subject_name: Valsartan


subject: CHEBI:9927


subject: CHEBI:9927


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Childhood Burkitt Leukemia


subject: CHEBI:31355

object_name: B-cell childhood acute lymphoblastic leukemia


subject: CHEBI:31355

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:31355

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: CHEBI:31355

object_name: Recurrent Childhood Large Cell Lymphoma


subject: CHEBI:31355

object_name: Childhood Immunoblastic Lymphoma


subject: CHEBI:31355

object_name: Recurrent Childhood Burkitt Lymphoma


subject: CHEBI:31355

object_name: Burkitt lymphoma


subject: CHEBI:31355

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:31355

object_name: Childhood Diffuse Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UNII:PVI5M0M1GW

object_name: epidermolysis bullosa dystrophica


subject: PR:000005932


subject: CHEBI:6801

subject_name: Metformin

object_name: schizophrenia


subject: CHEBI:6801

object_name: schizoaffective disorder


subject: CHEBI:6801

object_name: schizophrenia 18


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:9150


subject: CHEBI:9150


subject: CHEBI:5847

subject_name: Raltitrexed

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:5847


subject: CHEBI:149504

object_name: pediatric osteosarcoma


subject: CHEBI:149504

object_name: Osteosarcoma


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:38940


subject: CHEMBL.COMPOUND:CHEMBL5315126

subject_name: FOLLITROPIN BETA

object_name: infertility


subject: UMLS:C0060787

subject_name: follitropin beta


subject: CHEBI:135910

subject_name: Ganirelix


subject: UMLS:C0872894

subject_name: ganirelix acetate


subject: MESH:C000708971

subject_name: genexol-PM

object_name: Childhood Breast Carcinoma


subject: MESH:C000708971

object_name: breast carcinoma


subject: MESH:C000708971

object_name: breast cancer


subject: UNII:8C7XEW3K7S

subject_name: Bamocaftor

object_name: cystic fibrosis


subject: CHEBI:16349

subject_name: Citrulline

object_name: perinatal necrotizing enterocolitis


subject: CHEBI:16349

object_name: neuroendocrine carcinoma


subject: CHEBI:16349

object_name: necrotizing enterocolitis


subject: CHEBI:16349

object_name: bronchopulmonary dysplasia


subject: CHEBI:16349

object_name: pulmonary hypertension


subject: CHEBI:16349

object_name: Pulmonary Hypertension, CTCAE


subject: UNII:XRO4566Q4R

subject_name: INTERFERON BETA

object_name: multiple sclerosis


subject: CHEMBL.COMPOUND:CHEMBL3545030

object_name: narcolepsy


subject: CHEMBL.COMPOUND:CHEMBL4297877

subject_name: BALSTILIMAB

object_name: Advanced Melanoma


subject: UMLS:C4526708


subject: CHEMBL.COMPOUND:CHEMBL4650435

subject_name: BOTENSILIMAB


subject: UMLS:C4764272

subject_name: Botensilimab


subject: UMLS:C0359156

subject_name: Thymoglobulin

object_name: acquired aplastic anemia


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: Somatostatin Receptor Positive


subject: UNII:MRL3739G66

object_name: digestive system neuroendocrine tumor, grade 1/2


subject: UNII:MRL3739G66

object_name: head and neck cancer


subject: UNII:MRL3739G66

object_name: kidney cancer


subject: UNII:Y68179SY2L


subject: UNII:Y68179SY2L


subject: UNII:Y68179SY2L


subject: UNII:Y68179SY2L


subject: UMLS:C5855518

subject_name: Lead Pb 203 VMT-a-NET


subject: UMLS:C5855518


subject: UMLS:C5855518


subject: UMLS:C5855518


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: aortic stenosis


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: carcinoma of esophagus


subject: UNII:5S371K6132

object_name: esophageal cancer


subject: UNII:5S371K6132

object_name: Childhood Esophageal Carcinoma


subject: UNII:5S371K6132

object_name: neoplasm of esophagus


subject: CHEBI:46295

subject_name: Vardenafil

object_name: Tinnitus


subject: CHEBI:46295

object_name: Tinnitus, CTCAE 5.0


subject: CHEBI:46295

object_name: Tinnitus, CTCAE 3.0


subject: UMLS:C1170584

subject_name: Restasis

object_name: glaucoma


subject: UMLS:C1170584

object_name: Glaucoma, CTCAE


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: rectal carcinoma


subject: CHEBI:38290

object_name: rectal cancer


subject: CHEBI:38290

object_name: Childhood Rectal Carcinoma


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348

object_name: Throat cancer


subject: CHEBI:31348

object_name: oral cavity carcinoma


subject: CHEBI:31348

object_name: oral cavity cancer


subject: CHEBI:31348

object_name: Primary malignant neoplasm of skin of face


subject: CHEBI:31348

object_name: laryngeal carcinoma


subject: CHEBI:31348

object_name: larynx cancer


subject: CHEBI:3387

subject_name: Carbamazepine

object_name: neuralgia


subject: CHEBI:3387

object_name: Neuropathic pain


subject: CHEBI:61049

subject_name: Tacrolimus

object_name: poisoning


subject: CHEBI:61049

object_name: Disorder of transplanted kidney


subject: CHEBI:61049

object_name: Drug toxicity


subject: CHEBI:61049

object_name: neurotoxicity


subject: CHEBI:2668

subject_name: Amlodipine

object_name: Heart failure with normal ejection fraction


subject: PUBCHEM.COMPOUND:9800288

subject_name: METOPROLOL SUCCINATE

object_name: hypertension


subject: PUBCHEM.COMPOUND:9800288

object_name: Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:9800288


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: retinal vein occlusion


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: non-small cell squamous lung carcinoma


subject: UMLS:C5667045

object_name: non-small cell lung carcinoma


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:63605

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:63605

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:63605

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:63605

object_name: Prostate cancer recurrent


subject: CHEBI:63605

object_name: prostate adenocarcinoma


subject: PUBCHEM.COMPOUND:5458171

subject_name: MITOXANTRONE HYDROCHLORIDE


subject: PUBCHEM.COMPOUND:5458171


subject: PUBCHEM.COMPOUND:5458171


subject: PUBCHEM.COMPOUND:5458171


subject: PUBCHEM.COMPOUND:5458171


subject: PUBCHEM.COMPOUND:5458171


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: respiratory failure


subject: CHEBI:4466

object_name: bronchopulmonary dysplasia


subject: CHEBI:4466

object_name: Respiratory insufficiency


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: myasthenia gravis


subject: UMLS:C0003442

object_name: Myasthenia Gravis, CTCAE


subject: UMLS:C1446777

subject_name: Rabbit antigen


subject: UMLS:C1446777


subject: UMLS:C2093603

subject_name: Rabbit


subject: UMLS:C2093603


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: GTOPDB:4934

subject_name: G-CSF


subject: GTOPDB:4934


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: UNII:91D9GV0Z28

subject_name: Durapatite

object_name: Regenerative inflammation


subject: UNII:91D9GV0Z28

object_name: Osteopenia


subject: CHEBI:52254

subject_name: apatite


subject: CHEBI:52254


subject: CHEBI:9679


subject: CHEBI:9679


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:9150


subject: CHEBI:127780

subject_name: Foscarnet

object_name: cytomegalovirus retinitis


subject: CHEBI:127780

object_name: HIV infection


subject: CHEBI:465284

subject_name: Ganciclovir


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: migraine


subject: CHEBI:28787

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:70839

subject_name: Dasatinib

object_name: adult glioblastoma


subject: CHEBI:70839

object_name: Adult Gliosarcoma


subject: CHEBI:70839

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:70839

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: chronic rhinosinusitis


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:135449332

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:135449332

object_name: Solid Neoplasm


subject: DRUGBANK:DB15786

subject_name: Maritime pine extract

object_name: attention deficit hyperactivity disorder, inattentive type


subject: DRUGBANK:DB15786


subject: UMLS:C0072642

subject_name: Pycnogenol


subject: UMLS:C0072642


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Parenteral nutrition associated liver disease


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Pediatric Obesity


subject: UNII:83P3OQ67ZT


subject: UNII:83P3OQ67ZT


subject: UNII:83P3OQ67ZT


subject: UNII:83P3OQ67ZT

object_name: Metastatic malignant neoplasm to liver


subject: UNII:83P3OQ67ZT

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:83P3OQ67ZT

object_name: head and neck squamous cell carcinoma


subject: UNII:83P3OQ67ZT

object_name: triple-negative breast carcinoma


subject: UNII:83P3OQ67ZT

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:83P3OQ67ZT

object_name: skin carcinoma


subject: UNII:83P3OQ67ZT

object_name: colorectal carcinoma


subject: UNII:83P3OQ67ZT

object_name: Childhood Breast Carcinoma


subject: UNII:83P3OQ67ZT

object_name: breast carcinoma


subject: UNII:83P3OQ67ZT

object_name: breast cancer


subject: UNII:83P3OQ67ZT

object_name: cancer


subject: UNII:83P3OQ67ZT

object_name: neoplasm


subject: UNII:83P3OQ67ZT

object_name: melanoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:50858

subject_name: corticosteroid

object_name: asthma


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3540725

subject_name: Corticosteroid otologicals


subject: UMLS:C3539185

subject_name: Corticosteroid nasal preparations for topical use


subject: UMLS:C3540726

subject_name: Corticosteroid ophthalmologic and otologic preparations


subject: UMLS:C3540727

subject_name: Corticosteroids, topical for treatment of hemorrhoids and anal fissures


subject: UniProtKB:P19726

subject_name: CAPSA_BPT7 Major capsid protein (sprot)

object_name: poliomyelitis


subject: CHEBI:125628

subject_name: Alisertib

object_name: acute myeloid leukemia


subject: CHEBI:195559

subject_name: Poziotinib

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:162513664

subject_name: OBELDESIVIR


subject: DRUGBANK:DB18821

subject_name: Obeldesivir


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: Impaired glucose tolerance associated with drugs


subject: UMLS:C1099192


subject: CHEBI:50386

subject_name: cysteamine bitartrate

object_name: cystinosis


subject: CHEBI:50386

object_name: Fanconi renotubular syndrome


subject: CHEBI:50386

object_name: nephropathic cystinosis


subject: CHEBI:17141

subject_name: Cysteamine


subject: CHEBI:17141


subject: CHEBI:17141


subject: UNII:S66Z65E10T

subject_name: CEMDISIRAN

object_name: atypical hemolytic-uremic syndrome


subject: CHEBI:23965

subject_name: estradiol

object_name: Failed induction of labor


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: cervical polyp


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UNII:PE952ANF83

subject_name: Uproleselan

object_name: plasma cell myeloma


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: migraine


subject: UNII:971Z4W1S09

subject_name: Technetium Tc-99m sestamibi

object_name: coronary restenosis


subject: UNII:971Z4W1S09

object_name: type 2 diabetes mellitus


subject: CHEBI:33353

subject_name: technetium atom


subject: CHEBI:33353


subject: CHEBI:85188

subject_name: paritaprevir

object_name: hepatitis C


subject: CHEBI:85182

subject_name: Dasabuvir


subject: PUBCHEM.COMPOUND:76192587

subject_name: Ombitasvir


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: Newborn physiological jaundice


subject: CHEBI:5001


subject: CHEBI:6504

object_name: pervasive developmental disorder


subject: CHEBI:6504

object_name: autism


subject: CHEBI:6504

object_name: autism spectrum disorder


subject: UMLS:C0919144

subject_name: INJECTION, BASILIXIMAB, 20 MG Administered

object_name: Cooley's anemia


subject: UMLS:C0919144

object_name: beta thalassemia


subject: UNII:9927MT646M

subject_name: Basiliximab


subject: UNII:9927MT646M


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin


subject: UNII:D7RD81HE4W


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: CHEBI:16335

subject_name: Adenosine

object_name: Pathologic Processes


subject: CHEBI:16335

object_name: cardiomyopathy


subject: CHEBI:139072

object_name: Burnout, Psychological


subject: CHEBI:139072

object_name: Physical and emotional exhaustion state


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: PUBCHEM.COMPOUND:136634

subject_name: Dimethylamino


subject: PUBCHEM.COMPOUND:136634


subject: CHEBI:231996

subject_name: dimethylamino group


subject: CHEBI:231996


subject: UMLS:C1443000

subject_name: Chicken antigen

object_name: influenza


subject: UMLS:C1443000

object_name: viral disease


subject: DRUGBANK:DB10519

subject_name: Chicken


subject: DRUGBANK:DB10519


subject: UMLS:C2114799

subject_name: promestriene vaginal

object_name: Vulvovaginal Atrophy


subject: CHEBI:23965

subject_name: estradiol


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: hyperglycemia


subject: UMLS:C3714501

object_name: Hyperglycemia, CTCAE


subject: UMLS:C3714501

object_name: Glucose in blood specimen above reference range


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: CHEBI:5931


subject: CHEBI:3175

subject_name: Brimonidine

object_name: telangiectasis


subject: CHEBI:3175

object_name: Cutaneous telangiectasia


subject: UMLS:C0390856

subject_name: human papillomavirus vaccine, TA

object_name: cervical cancer


subject: UMLS:C0390856

object_name: cervical carcinoma


subject: UMLS:C0390856

object_name: precancerous condition


subject: CHEBI:36704

subject_name: Imiquimod


subject: CHEBI:36704


subject: CHEBI:36704


subject: PUBCHEM.COMPOUND:91933514


subject: PUBCHEM.COMPOUND:91933514


subject: PUBCHEM.COMPOUND:91933514


subject: CHEBI:232588


subject: CHEBI:232588


subject: CHEBI:232588


subject: UniProtKB:P06788

subject_name: VE7_HPV18 Protein E7 (sprot)


subject: UniProtKB:P06788


subject: UniProtKB:P06788


subject: UMLS:C1335333

subject_name: Papillomavirus Transforming Protein E7


subject: UMLS:C1335333


subject: UMLS:C1335333


subject: UniProtKB:P04020

subject_name: VE7_HPV11 Protein E7 (sprot)


subject: UniProtKB:P04020


subject: UniProtKB:P04020


subject: UMLS:C0674607

subject_name: detox adjuvant


subject: UMLS:C0674607


subject: UMLS:C0674607


subject: UMLS:C4742121

object_name: Cirrhosis


subject: UMLS:C4742121

object_name: liver cirrhosis


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:63580


subject: CHEBI:59495

subject_name: CIDOFOVIR

object_name: Genital warts


subject: CHEBI:59495

object_name: HIV infection


subject: CHEBI:530615


subject: CHEBI:530615


subject: CHEBI:134514


subject: CHEBI:134514


subject: CHEBI:3696

subject_name: Cidofovir


subject: CHEBI:3696


subject: UMLS:C3248394

subject_name: Injection, ipilimumab, 1 mg administered

object_name: Mesothelioma


subject: UMLS:C3248394

object_name: mesothelial neoplasm


subject: UMLS:C3248394

object_name: malignant mesothelioma


subject: UMLS:C5203457

subject_name: Ipilimumab Liquid Injection


subject: UMLS:C5203457


subject: UMLS:C5203457


subject: UMLS:C5203423

subject_name: Nivolumab Liquid Injection


subject: UMLS:C5203423


subject: UMLS:C5203423


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Biochemically Recurrent Prostate Carcinoma


subject: UNII:28X28X9OKV

object_name: prostate adenocarcinoma


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: UMLS:C5447413

subject_name: TLR7 Agonist RO7119929

object_name: biliary tract cancer


subject: UMLS:C5447413

object_name: Metastatic malignant neoplasm to liver


subject: UMLS:C5447413

object_name: liver carcinoma


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: cancer


subject: CHEBI:25681

object_name: neoplasm


subject: CHEBI:25681

object_name: Diabetes


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: plasma cell myeloma


subject: CHEBI:2948

subject_name: Azathioprine

object_name: pemphigus vulgaris


subject: PUBCHEM.COMPOUND:126843196

subject_name: Recombinant insulin Human

object_name: septic shock


subject: CHEBI:5931

subject_name: insulin human


subject: UMLS:C1446598

subject_name: Recombinant human regular insulin


subject: UMLS:C0306371

subject_name: Humulin R


subject: CHEBI:6801

subject_name: Metformin

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:6801

object_name: metabolic syndrome X


subject: CHEBI:6801

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: ovarian disease


subject: CHEBI:41879

object_name: malignant endocrine neoplasm


subject: CHEBI:41879

object_name: endocrine gland neoplasm


subject: CHEBI:41879

object_name: female reproductive system disorder


subject: CHEBI:41879


subject: CHEBI:41879

object_name: Adnexal Diseases


subject: CHEBI:41879


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN


subject: PUBCHEM.COMPOUND:49865963

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:49865963

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:49865963


subject: PUBCHEM.COMPOUND:49865963


subject: PUBCHEM.COMPOUND:49865963


subject: PUBCHEM.COMPOUND:49865963


subject: PUBCHEM.COMPOUND:49865963


subject: PUBCHEM.COMPOUND:49865963


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: PUBCHEM.COMPOUND:3199


subject: CHEBI:63631

subject_name: Topiramate

object_name: Seizure Related to COVID-19


subject: CHEBI:63631

object_name: visual epilepsy


subject: UNII:I60W9520VV

subject_name: Vadadustat

object_name: anemia


subject: UNII:I60W9520VV

object_name: Anemia, CTCAE


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus

object_name: metastatic colorectal cancer


subject: UMLS:C0962969

subject_name: RAD 001

object_name: head and neck cancer


subject: UMLS:C0962969

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: UNII:T5W3M0VO9B

object_name: ulcerative colitis


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: schizophrenia


subject: UNII:6E01CG547T

subject_name: MITOQUINONE MESYLATE

object_name: Exposure to cold


subject: UMLS:C5690695

subject_name: mitoquinone mesylate


subject: UMLS:C5690696

subject_name: MitoQ


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: interstitial lung disease


subject: CHEBI:85164


subject: UMLS:C4045524

object_name: Childhood Solid Neoplasm


subject: UMLS:C4045524

object_name: Adult Solid Neoplasm


subject: UMLS:C4045524

object_name: Solid Neoplasm


subject: UMLS:C4733303

object_name: follicular lymphoma


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:4026

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: Stomach cancer


subject: GTOPDB:9758

object_name: gastric cancer


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: CHEBI:87715

subject_name: Prasugrel

object_name: acute coronary syndrome


subject: CHEBI:143528

subject_name: DL-Arabinose

object_name: Slow transit constipation


subject: UNII:89NA02M4RX

subject_name: PECTIN


subject: CHEBI:17309

subject_name: pectin


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Childhood Idiopathic Nephrotic Syndrome


subject: UMLS:C0295415

subject_name: rituximab


subject: PR:000010478

subject_name: matrix metalloproteinase-19

object_name: Chagas cardiomyopathy


subject: PR:000010478

object_name: dilated cardiomyopathy


subject: PR:000010478

object_name: heart failure


subject: PR:000010478

object_name: Heart Failure, CTCAE


subject: CHEBI:3441

subject_name: Carvedilol


subject: CHEBI:3441


subject: CHEBI:3441


subject: CHEBI:3441


subject: CHEBI:135990

subject_name: Gepirone

object_name: cocaine abuse


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: chronic pain (diagnosis)


subject: CHEBI:3160

object_name: Chronic pain


subject: CHEBI:3160

object_name: neuralgia


subject: CHEBI:3160

object_name: Neuralgia, CTCAE


subject: PUBCHEM.COMPOUND:16681698

subject_name: Obatoclax mesylate

object_name: Hodgkin Disease


subject: CHEBI:94522


subject: UNII:39200FJ43J

subject_name: [OBSOLETE] obatoclax mesylate


subject: UMLS:C1831948

subject_name: obatoclax mesylate


subject: UMLS:C1831949


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Neck Carcinoma


subject: CHEBI:114785

object_name: head and neck neoplasm


subject: CHEBI:114785

object_name: head and neck cancer


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: prostate carcinoma


subject: CHEBI:25681

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:131751561

subject_name: Cyclostenol


subject: PUBCHEM.COMPOUND:131751561


subject: DRUGBANK:DB14276

subject_name: Turmeric


subject: DRUGBANK:DB14276


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: CHEBI:89324


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN


subject: PUBCHEM.COMPOUND:5281767


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: Recurrent ovarian cancer


subject: CHEBI:41774

object_name: Ovarian cancer stage III


subject: CHEBI:41774

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:41774

object_name: Ovarian cancer stage IV


subject: CHEBI:74947

subject_name: Thalidomide

object_name: fallopian tube carcinoma


subject: CHEBI:74947

object_name: fallopian tube cancer


subject: CHEBI:74947


subject: CHEBI:74947


subject: CHEBI:74947


subject: CHEBI:74947


subject: CHEBI:74947

object_name: peritoneum cancer


subject: DRUGBANK:DB14297

subject_name: Arnica montana

object_name: cutaneous leishmaniasis


subject: UMLS:C0439995

subject_name: Arnica tincture (substance)


subject: UMLS:C1145201

subject_name: INJECTION, PARICALCITOL, 1 MCG

object_name: secondary hyperparathyroidism